Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a consolidated 'Locations' section listing sites in CA, GA, IL, OR, PA, and TN and removed the separate 'California Locations', 'Georgia Locations', 'Illinois Locations', 'Oregon Locations', 'Pennsylvania Locations', and 'Tennessee Locations' headers. Revision updated to v3.3.3.SummaryDifference0.6%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision: v3.3.2 added and Revision: v3.2.0 removed, likely representing backend version updates rather than changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedThe generic government funding/operating status notice was removed. Core study content such as objectives, design, eligibility, and locations remains unchanged.SummaryDifference0.3%

- Check70 days agoChange DetectedNo significant changes detected; the page title and content appear unchanged between the screenshots.SummaryDifference0.3%

- Check99 days agoChange DetectedCore page now shows a government funding notice and operating-status links (v3.2.0); a prior resource entry (Small cell lung carcinoma) at v3.1.0 was removed.SummaryDifference2%

- Check106 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.